Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches
Patel Nishant,
Woo Jason,
Liss A. Michael,
Palazzi L. Kerrin,
Randall Michael J.,
Mehrazin Reza,
Jabaj Ramzi,
Mirheydar S. Hossein,
Gillis Kyle,
Lee J. Hak,
Patterson L. Anthony,
Kane J. Christopher,
Millard Frederick,
Derweesh H. Ithaar,
;
Department of Urology, University of California San Diego Health System, La Jolla, California, USA
Apr
2016 (Vol.
23, Issue
2, Pages(
8227 - 8233)
PMID: 27085828